Shandong Sinobioway Biomedicine (SHE:002581), through unit Shandong Yandu Biotechnology, signed a 54 million yuan purchase deal to buy materials for its human nerve growth factor eye drops, according to a Shenzhen Stock Exchange disclosure on Wednesday.
Under the deal, Yandu Biotechnology will purchase storage liquid and chromatography systems, fillers, and reaction bags from Jiangsu Suhao Innovation Technology Group, the Chinese pharmaceutical company said.
The amount included nearly 14 million yuan for the fillers and reaction bags and around 40 million yuan for the storage liquid and chromatography systems.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.